Skip to main content
. Author manuscript; available in PMC: 2015 Apr 1.
Published in final edited form as: Cancer Prev Res (Phila). 2014 Jan 21;7(4):418–425. doi: 10.1158/1940-6207.CAPR-13-0367

Table 2.

Hazard ratios (HRs) and 95% confidence intervals (CIs) for thyroid cancer according to reproductive and hormonal factors.

All Thyroid Papillary Carcinoma

Cases HR (95% CI)a Cases HR (95% CI)a
Age at menarche
 <12 years 33 1.00 (reference) 25 1.00 (reference)
 12–13 years 70 0.84 (0.55–1.27) 57 0.91 (0.57–1.46)
 ≥14 years 24 0.62 (0.36–1.05) 17 0.60 (0.32–1.11)
 P-trendb 0.08 0.11
Type of menopause
 Natural 74 1.00 (reference) 58 1.00 (reference)
 Hysterectomy, both ovaries removed 17 1.21 (0.71–2.06) 16 1.47 (0.84–2.56)
 Hysterectomy, still has ≥1 ovaries/unknown 31 1.22 (0.80–1.86) 22 1.13 (0.69–1.85)
Age at natural menopausec,e
 <50 years 21 1.00 (reference) 14 1.00 (reference)
 50–54 years 34 1.08 (0.62–1.86) 29 1.38 (0.73–2.61)
 ≥55 years 19 2.24 (1.20–4.18) 15 2.65 (1.28–5.51)
 P-trendb 0.02 0.01
Number of reproductive yearsd,e
 <35 years 20 1.00 (reference) 14 1.00 (reference)
 35–40 years 27 0.83 (0.46–1.48) 22 0.96 (0.49–1.88)
 >40 years 27 1.71 (0.96–3.07) 22 1.97 (1.00–3.87)
 P-trendb 0.05 0.03
Lifetime number of ovulatory cyclese
 <415 cycles 22 1.00 (reference) 16 1.00 (reference)
 415–489 cycles 28 1.27 (0.73–2.23) 25 1.54 (0.82–2.90)
 ≥ 490 cycles 24 2.40 (1.33–4.30) 17 2.27 (1.13–4.53)
 P-trendb 0.01 0.02
Number of live births
 Nulliparous 13 1.40 (0.69–2.85) 9 1.06 (0.44–2.60)
 1 or 2 34 1.00 (reference) 26 1.00 (reference)
 3 27 0.98 (0.59–1.63) 22 1.06 (0.60–1.87)
 4 19 1.04 (0.59–1.83) 13 0.94 (0.48–1.85)
 ≥5 34 1.72 (1.05–2.82) 29 1.98 (1.14–3.43)
 P-trendb,f 0.04 0.03
Age at birth of first child among parous womend
 <20 years 26 1.00 (reference) 19 1.00 (reference)
 20–24 years 60 0.83 (0.51–1.34) 47 0.89 (0.51–1.56)
 ≥25 27 0.60 (0.34–1.08) 23 0.68 (0.35–1.33)
 P-trendb 0.09 0.26
Tried becoming pregnant without success
 Never 107 1.00 (reference) 84 1.00 (reference)
 Ever 20 1.10 (0.68–1.77) 15 1.05 (0.60–1.82)
Oral contraceptive use
 Never 51 1.00 (reference) 42 1.00 (reference)
 Ever 76 1.15 (0.79–1.68) 57 1.05 (0.69–1.60)
Hormone therapy status
 Never 41 1.00 (reference) 33 1.00 (reference)
 Former 18 0.86 (0.50–1.50) 14 0.83 (0.45–1.56)
 Current 68 0.99 (0.67–1.49) 52 0.94 (0.60–1.48)
Tubal Ligation
 Never 89 1.00 (reference) 70 1.00 (reference)
 Ever 38 1.46 (0.99–2.16) 29 1.42 (0.91–2.23)
a

Adjusted for education (less than high school graduate, high school graduate, college graduate), race (non-Hispanic white, non-Hispanic black, Hispanic, Asian/Pacific Islander/American Indian), marital status (married or living as married, widowed, divorced/separated, never married), family history of thyroid cancer, baseline BMI status (<25 kg/m2, 25–29 kg/m2, ≥30 kg/m2), and smoking status (never smoked, former smoker, current smoker) with attained age as the underlying time variable

b

P-trend calculated by modeling the categorical variable as continuous

c

Age at natural menopause defined as when the participant reported having their last period

d

Number of years between age at menarche and age at natural menopause

e

Restricted to women with natural menopause

f

Excludes participants reporting never pregnant or no live births